This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Valeo Pharma Inc.
Valeo Pharma Inc., a prominent Canadian pharmaceutical company, is headquartered in Laval, Quebec, with significant operations across North America. Founded in 2003, Valeo Pharma has established itself in the healthcare industry, focusing on the development and commercialisation of innovative prescription medications. The company’s core product offerings include a range of therapeutic solutions in areas such as oncology, neurology, and respiratory health, distinguished by their commitment to addressing unmet medical needs. Valeo Pharma has achieved notable milestones, including strategic partnerships and product launches that have solidified its market position. With a dedication to enhancing patient outcomes, Valeo Pharma continues to make strides in the pharmaceutical landscape, driven by a robust pipeline and a focus on quality and efficacy.
DitchCarbon Score
How does Valeo Pharma Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Valeo Pharma Inc.'s score of 23 is lower than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Valeo Pharma Inc.'s reported carbon emissions
Valeo Pharma Inc., headquartered in Canada, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company has not established documented reduction targets or commitments to climate initiatives, which suggests a lack of formalised strategies in this area. As a current subsidiary, Valeo Pharma Inc. may inherit climate-related data and initiatives from its parent organisation; however, no specific details or metrics have been provided regarding such cascaded information. This absence of data limits the ability to assess their carbon footprint or climate commitments effectively. In the broader context of the pharmaceutical industry, companies are increasingly recognising the importance of sustainability and climate action. Valeo Pharma Inc. may need to consider developing and communicating clear climate commitments to align with industry standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Valeo Pharma Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
